menu search

Creative medical shares soar on positive data from stemspine pilot study

Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemS...

March 23, 2022, 10:15 am

Avadel pharmaceuticals plc: initiating buy, bye bye to sleepiness

We are initiating AVDL at a speculative buy rating, with a target price of USD 14....

March 21, 2022, 9:46 am

Alpine immune sciences, inc. (alpn) reports q4 loss, misses revenue estimates

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -100% and 45.18%, respe...

March 17, 2022, 6:48 pm

Aquestive's aqst-109 receives fast track tag for allergic reactions

The FDA has granted Fast Track Designation to Aquestive Therapeutics Inc's (NASDAQ: AQST) AQST-109 for allergic reactions. AQST-109 is an orally del...

March 17, 2022, 11:20 am

Haywood capital markets repeats 'buy' on red pine exploration following darwin-grace drill results at wawa project

Haywood Capital Markets has repeated a 'Buy' rating on Red pine Exploration Inc (TSX-V:RPX, OTCQB:RDEXF...

March 17, 2022, 11:18 am

Nls pharma shares fall after mazindol er interim data shows 39% improvement on sleepiness scale

NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol ...

March 16, 2022, 2:06 pm

Red pine exploration says drilling at darwin-grace area at wawa property underlines the former mine's gold potential

Red pine Exploration Inc (TSX-V:RPX, OTCQB:RDEXF) has reported encouraging drill results from the Darwi...

March 16, 2022, 8:25 am

Epr properties: those darn tenants keep paying rent

Many opined during the pandemic that the heavy dependence of EPR Properties (EPR) on theatres would be ...

March 16, 2022, 6:30 am

Red pine exploration announces publication of its inaugural 2021 esg report

Red pine Exploration Inc (TSX-V:RPX, OTCQB:RDEXF) has announced the publication of its inaugural 2021 E...

March 15, 2022, 7:54 am

Alpine (alpn) down on fda partial clinical hold on cancer study

The FDA places a partial clinical hold on Alpine's (ALPN) NEON-2 study evaluating the combo of davoceti...

March 8, 2022, 12:47 pm

Renault takes wraps off new austral suv with 'alpine' finish

French carmaker Renault unwrapped its new Austral SUV on Tuesday, marking its latest effort to compete in the compact car segment while moving upmarke...

March 8, 2022, 9:40 am

Why alpine immune's shares are falling today

The FDA has placed a partial clinical hold on Alpine Immune Sciences Inc's (NASDAQ: ALPN) NEON-2 tr...

March 7, 2022, 12:13 pm

Why alpine immune's shares are falling today

The FDA has placed a partial clinical hold on Alpine Immune Sciences Inc's (NASDAQ: ALPN) NEON-2 tr...

March 7, 2022, 12:13 pm

Why alpine immune's shares are falling today

The FDA has placed a partial clinical hold on Alpine Immune Sciences Inc's (NASDAQ: ALPN) NEON-2 tr...

March 7, 2022, 12:13 pm

Globus medical continues to flex its innovation muscles to drive share growth

Globus has continued to gain share in the U.S. spine market, helping to drive a decent Q4'21 revenue be...

March 1, 2022, 12:34 pm

Globus medical continues to flex its innovation muscles to drive share growth

Globus has continued to gain share in the U.S. spine market, helping to drive a decent Q4'21 revenue be...

March 1, 2022, 12:34 pm

Globus medical continues to flex its innovation muscles to drive share growth

Globus has continued to gain share in the U.S. spine market, helping to drive a decent Q4'21 revenue be...

March 1, 2022, 12:34 pm

Alpine immune sciences announces participation in march investor conferences

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunot...

March 1, 2022, 8:05 am

Alpine immune sciences announces participation in march investor conferences

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunot...

March 1, 2022, 8:05 am

Alpine immune sciences announces participation in march investor conferences

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunot...

March 1, 2022, 8:05 am


Search within

Pages Search Results: